Tian Wenzhi - Net Worth and Insider Trading

Tian Wenzhi Net Worth

The estimated net worth of Tian Wenzhi is at least $989 Million dollars as of 2024-06-21. Tian Wenzhi is the 2501 Other of ImmuneOnco Biopharmaceuticals (Shanghai) Inc and owns about 68,269,973 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) stock worth over $989 Million. Details can be seen in Tian Wenzhi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tian Wenzhi has not made any transactions after 2023-09-05 and currently still holds the listed stock(s).

Transaction Summary of Tian Wenzhi

To

Tian Wenzhi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tian Wenzhi owns 1 companies in total, including ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) .

Click here to see the complete history of Tian Wenzhi’s form 4 insider trades.

Insider Ownership Summary of Tian Wenzhi

Ticker Comapny Transaction Date Type of Owner
HKSE:01541 ImmuneOnco Biopharmaceuticals (Shanghai) Inc 2023-09-05 2501 Other

Tian Wenzhi Latest Holdings Summary

Tian Wenzhi currently owns a total of 1 stock. Tian Wenzhi owns 68,269,973 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) as of September 5, 2023, with a value of $989 Million.

Latest Holdings of Tian Wenzhi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:01541 ImmuneOnco Biopharmaceuticals (Shanghai) Inc 2023-09-05 68,269,973 14.48 988,549,209

Holding Weightings of Tian Wenzhi


Tian Wenzhi Form 4 Trading Tracker

According to the SEC Form 4 filings, Tian Wenzhi has made a total of 1 transactions in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in ImmuneOnco Biopharmaceuticals (Shanghai) Inc is the sale of 68,269,973 shares on September 5, 2023, which brought Tian Wenzhi around $0.

Insider Trading History of Tian Wenzhi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tian Wenzhi Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Tian Wenzhi Ownership Network

Ownership Network List of Tian Wenzhi

No Data

Ownership Network Relation of Tian Wenzhi

Insider Network Chart

Tian Wenzhi Owned Company Details

What does ImmuneOnco Biopharmaceuticals (Shanghai) Inc do?

Who are the key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc?

Tian Wenzhi is the 2501 Other of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Other key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc include Ho Yao , CHENG YIQUAN , and 2102 Investment manager LAV Asset Management (Hong Kong) Limited .

ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) Insider Trades Summary

Over the past 18 months, Tian Wenzhi made 1 insider transaction in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) with a net sale of 0. Other recent insider transactions involving ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) include a net sale of 0 shares made by Halo Biomedical LP , a net sale of 0 shares made by GBA Fund Investment Limited , and a net sale of 0 shares made by CHENG YIQUAN .

In summary, during the past 3 months, insiders sold 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Insider Transactions

No Available Data

Tian Wenzhi Mailing Address

Above is the net worth, insider trading, and ownership report for Tian Wenzhi. Currently GuruFocus does not have mailing address information for Tian Wenzhi.

Discussions on Tian Wenzhi

No discussions yet.